Main page content begins

Corporate/M&A 

The U.S. corporate/M&A team represents a wide range of leading U.S. and international corporations, financial institutions and private equity funds. The team has extensive experience with both public and private domestic and cross-border transactions.

Representative experience includes advising:

  • Novartis in its transformational restructuring involving three strategic deals with GlaxoSmithKline (GSK), including the acquisition of GSK’s oncology division, the sale of Novartis’ vaccines business and the creation of a joint venture involving the combination of Novartis’ OTC business with GSK’s consumer healthcare business
  • AMEC in connection with its acquisition of Foster Wheeler
  • Visa Europe Limited on the sale of 100% of its share capital to Visa Inc.
  • Petrochemical Industries Company K.S.C. in the US$3.2bn sale of MEGlobal, together with its joint venture partner Dow Chemical, to EQUATE Petrochemical Company K.S.C.C.
  • Qatar Holding L.L.C., an affiliate of the Qatar Investment Authority, along with funds under management by BlackRock, Macquarie, Teacher Retirement System of Texas and Certares on the US$1.8bn acquisition of a 50% stake in American Express' Global Business Travel unit (2015 Private Equity Deal of the Year, IFLR Americas Awards)
  • ASSA ABLOY on its acquisitions of Amarr Company, Ameristar Fence Products and 4Front Engineered Solutions
  • ThyssenKrupp on the sale of its U.S. steel plant to ArcelorMittal and Nippon Steel & Sumitomo Metal Corp.
  • Deutsche Börse on its terminated merger with NYSE-Euronext to create the world’s largest stock exchange by revenue and profits
  • E-Land World Ltd. on its US$170m acquisition of K-Swiss, Inc.
  • IFM Investors on its US$1.3bn investment  for Freeport LNG's proposed natural gas liquefaction and LNG loading facility on Quintana Island near Freeport, Texas
  • Vodafone on its £9.1bn offer for Kabel Deutschland
  • a major automobile rental company on the global investment in and strategic cooperation with a major Chinese auto rental company
  • Queijo Holding Corp., a vehicle of the controlling stockholders – Acquisition of the all of the shares not owned by the controlling shareholders in Brazil Fast Food Corp., valuing the latter at US$148.3m
  • Actavis on its €4.25bn sale to Watson Pharmaceuticals 
  • Sanofi-aventis on its acquisition of Merck & Co.’s half of joint venture Merial, an animal-health company
  • Amil Participações on its US$4.9bn investment agreement with UnitedHealthcare (2013 Global M&A Deal of the Year (Brazil), The American Lawyer Global Legal Awards)
  • a consortium of sovereign wealth and private equity investors on a US$1.8bn acquisition of a minority stake in Banco BTG Pactual (2011 Best Private Equity Deal of the Year, Latin Finance Magazine)
  • Gold Fields, National Grid, RBS, Rio Tinto, Sibanye Gold and Vodafone on SEC-related matters, including reporting and corporate governance

Contacts

Mike Bienenfeld
Partner, London
(4420) 7456 3660
mike.bienenfeld@linklaters.com

 

Peter Cohen-Millstein

Partner, New York

(1) 212 903 9424

peter.cohen-millstein@linklaters.com

 

William Kirschner
Partner, Singapore
(65) 6692 5758
william.kirschner@linklaters.com

  

Alberto Luzárraga
Partner, New York, Sao Paulo

(1) 212 903 9026 (New York)

(55 11) 3074 9522 (São Paulo)
alberto.luzarraga@linklaters.com

 

Scott Sonnenblick

Partner, New York
(1) 212 903 9292

scott.sonnenblick@linklaters.com

 

Tom Shropshire

Partner, Global U.S. Practice Head

(44 20) 7456 3223

tom.shropshire@linklaters.com